How to treat improper insulin injection-related lipohypertrophy: A 3-year follow-up of a monster case and an update on treatment
Gentile S, Guarino G, Strollo F
Diabetes Res Clin Pract. Pub. online 9 November 2020
Leggi
Breaking news
Contemporary management of heart failure in patients with diabetes
Shaw JA, Cooper ME
Diabetes Care 2020;43(12):2895-903
Leggi
Physical activity guidelines 2020: comprehensive and inclusive recommendations to activate populations
Ding D, Mutrie N, Bauman A, et al.
The Lancet. Pub. online 25 November 2020
Leggi
Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial
McGuire DK, Zinman B, Inzucchi SE, et al.
Lancet Diabetes Endocrinol. 2020;8(12):949-959
Leggi
Hyperglycemia and adverse pregnancy outcome follow-up study: newborn anthropometrics and childhood glucose metabolism
Bianco ME, Kuang A, Josefson JL, et al.
Diabetologia. Pub. online16 November 2020
Leggi
Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
Ipsen EØ, Madsen KS, Chi Y, et al.
Cochrane Database Syst Rev. 2020;11:CD013516
Leggi
2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial
Al-Mrabeh A, Hollingsworth KG, Shaw JAM, et al.
Lancet Diabetes Endocrinol. 2020;8(12):939-948.
Leggi
Golimumab and beta-cell function in youth with new-onset type 1 diabetes
Quattrin T, Haller MJ, Steck AK, et al.
N Engl J Med. 2020;383:2007-17
Leggi
Sotagliflozin in patients with diabetes and chronic kidney disease
Bhatt DL, Szarek M, Pitt B, et al.
N Engl J Med. 2020 Nov 16
Leggi
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials
Gencer B, Marston NA, Im KA, et al.
The Lancet. Pub online 10 November 2020
Leggi